Navigation Links
Circassia Acquires North American and Japanese Rights to Dopexamine
Date:10/8/2008

Circassia Establishes Commercial-Scale Supply Chain

Circassia to Develop Dopexamine as Part of Proprietary Post-Surgery

Recovery Protocols

OXFORD, England, October 8 /PRNewswire/ -- Circassia Ltd, a specialty biopharmaceutical company focused on the fields of allergy and critical care, announced today that it has acquired the US, Canadian and Japanese development and commercialization rights to dopexamine from the international speciality pharmaceutical company Ipsen. Circassia has also entered into agreements with pharmaceutical manufacturers Excella and Hospira to establish a commercial-scale supply chain for the product.

Circassia is developing dopexamine in a new indication as an integral part of proprietary structured protocols designed to dramatically improve patient recovery following a range of high-risk surgeries. This novel approach, named ToleroCare(R), which Circassia has recently patented, combines the use of dopexamine with the administration of intra-venous fluids to improve tissue oxygenation levels during the recovery period after surgery. The precise use of fluids and dopexamine is based on carefully defined parameters such as heart stroke volume and oxygen delivery index.

ToleroCare therapy has already achieved clinical proof-of-concept in a phase II single-blind, randomized, controlled trial in 122 high-risk general surgery patients in the UK. The study showed that significantly fewer patients who received ToleroCare experienced complications in the 30 day period following surgery compared with those on standard treatment (44% vs. 68%; p = 0.003). In addition, ToleroCare patients recovered significantly quicker, staying in hospital for 17.5 days on average compared with 29.5 days (p = 0.001) for those who received standard therapy.

Dopexamine is a beta2 adrenoceptor and dopamine receptor agonist, which is approved in Europe in indications related to heart failure. Dop
'/>"/>

SOURCE Circassia Ltd
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Circassia Raises GBP11 Million ($21.8 Million) in Oversubscribed Second Round Funding
2. Circassia Initiates Phase II Clinical Study With Novel Anti-Allergy Technology
3. Clinical Data Acquires Epidauros Biotechnologie AG, Significantly Enhancing Proprietary Genetic Biomarker Portfolio
4. Neogen Acquires Kane Enterprises
5. OncoVista, Inc. Closes on $6.8 Million Financing and Acquires Control of a Public Shell Company
6. Thermo Fisher Scientific Acquires Instrument Sales Business of Davis Inotek
7. United BioSource Acquires Interest in Leading Adaptive Design Technology Service Provider
8. NSF International Acquires David Begg Associates
9. United BioSource Acquires Caro Research, Leader in Simulation Modeling
10. Respironics Acquires Apollo Light Systems, Inc., Expands into Circadian Rhythm Device-Based Therapy Market
11. Thermo Fisher Scientific Acquires Logistics Provider to Strengthen Clinical Trials Management Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... 2014 Histogen, Inc., a regenerative medicine ... grown under simulated embryonic conditions, today announced that they ... Medical, Inc. for physician-dispensed aesthetic products containing Histogen’s proprietary ... agreement is an amendment to the existing license between ...
(Date:1/14/2014)... 14, 2014 EquitiesIQ, a leading informational ... ALQA). Alliqua is an emerging biomedical company acquiring, developing, ... care market. , Free report download: http://equitiesiq.com/reports/alliqua/ ... seasoned management team and Board, which launched the company’s ...
(Date:1/14/2014)... iLab Solutions, the leader in core facility management software, today ... In this role, Michelle will work with current and potential ... development of iLab products. Her main goal will be to ... scientific community by offering the most advanced, user-friendly, and high-impact ...
(Date:1/14/2014)... January 14, 2014 Global Record ... innovative information technology solutions for patients, physicians, the ... stakeholders, announced today the signing of a three-year ... and Drug Administration (FDA). This initiative is ...
Breaking Biology Technology:Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 2Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 3EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3iLab Solutions Announces Michelle Detwiler as the New Director of Product Strategy 2Global Record Systems Announces Research Collaboration Agreement with FDA to Create a Novel “Big Data” Paradigm for Collection of Patient Safety and Outcomes Information 2
... today announced the addition of two new members to ... , ,The Madison-based media communications company hopes to broaden ... board of directors with the appointments. Peercy and Weis ... at which time they will stand for election. , ...
... and creators of corporate intranets are frustrated. In a ... Internet was their primary information resource at work, but ... main source of information. Given all the money and ... users find so little value in them? , ,By ...
... million incentive package announced today from the state of ... announced that it will build a new $85 million ... Gov. Jim Doyles financial package is intended to assist ... , ,The new 475,000-square-foot facility will house the companys ...
Cached Biology Technology:The unfilled promise of corporate intranets 2The unfilled promise of corporate intranets 3GE Healthcare gets $7 million package from governor to stay in state 2
(Date:4/23/2014)... early fetal death according to a new study by ... Los Angeles and Ulaanbaatar, Mongolia the coldest capital ... today in the journal BMC Pregnancy and Childbirth ... ambient air pollutants and pregnancy loss in Ulaanbaatar (UB), ... levels of air pollution of all world capitals, with ...
(Date:4/23/2014)... the Indiana University School of Public Health-Bloomington has bolstered ... by finding a strong association between heme iron, found ... , The study found that heme iron consumption increased ... while no association was found between nonheme iron, which ... heart disease. , The study was published online ahead ...
(Date:4/23/2014)... in their mid-thirties and forties, face a devastating ... two decades. "Mutant" protein clusters, long blamed for ... the primary focus of therapies in development by ... Prof. Gerardo Lederkremer and Dr. Julia Leitman of ... Immunology, in collaboration with Prof. Ulrich Hartl of ...
Breaking Biology News(10 mins):Pollutants from coal-burning stoves strongly associated with miscarriages in Mongolia 2Study: Iron consumption can increase risk for heart disease 2On the defensive 2On the defensive 3
... CAMDEN When kitchens become infiltrated with fruit flies, especially ... the flying pests would just turn to ice. The ... genetic system making it an ideal organism to test a ... Shutting off this molecular thermostat could result in a newfound ...
... workshop is designed to provide students with an insight ... Geographic Society (NGS). It will feature an overview ... exploration for NGS; information from Rebecca Martin, director of ... grant recipients; and a panel discussion including NGS Emerging ...
... Pablo Sobrado, assistant professor of biochemistry with the Fralin Life ... grant from the National Science Foundation (NSF) to advance his ... mycobacteria. Iron is essential for all life. The ... Aspergillus fumigatus and Mycobacterium tuberculosis need. To ...
Cached Biology News:Frozen flies may yield secrets for human organ transplants 2Research targets basic metabolism of disease-causing fungi, bacteria 2
PFM8 Antibody...
Rabbit polyclonal to NCoR2, prediluted ( Abpromise for all tested applications). entrezGeneID: 9612 SwissProtID: Q9Y618...
Goat anti-PITPN Class: Antibody Product Group: Miscellaneous Antibody...
Goat polyclonal to Nebraska Calf Diarrhea Virus (FITC) ( Abpromise for all tested applications). Antigen: Bovine (Nebraska Calf Diarrhea Virus)....
Biology Products: